News
Harvard Researchers Develop AI-Driven Framework To Study Social Interactions, A Step Forward for Autism Research
News
Harvard Innovation Labs Announces 25 President’s Innovation Challenge Finalists
News
Graduate Student Council To Vote on Meeting Attendance Policy
News
Pop Hits and Politics: At Yardfest, Students Dance to Bedingfield and a Student Band Condemns Trump
News
Billionaire Investor Gerald Chan Under Scrutiny for Neglect of Historic Harvard Square Theater
Twenty-two sufferers of the heart disease angina pectoris have received relief from a radioactive iodine treatment developed by Dr. Herman L. Rlumgart 17, Dr. A. Stone Freedberg '29, and Dr. George S. Kurland '40 of the Medical School.
The doctors emphasize that their method is not a cure, but merely a means of enabling the afflicted persons to lead more normal lives.
Radioactive fading, explain the doctors, slows down the tempo of the body by reducing the amount of thyroxin secreted from the thyroid gland. The work load on the heart is thus reduced.
Final evaluation of this kind of therapy however, must await prolonged study, they cautioned.
Want to keep up with breaking news? Subscribe to our email newsletter.